endometriosis
Hormone study could support blood test for endometriosis
July 8, 2026Research and Development endometriosis
Researchers at the University of Edinburgh have identified a distinct hormone profile associated with endometriosis that could lead to the …
Phase 2 endometriosis trial reaches recruitment milestone
June 15, 2026Research and Development Gesynta Pharma, endometriosis
Gesynta Pharma has announced that 50% of the target enrolment has been reached in its phase 2 NOVA trial evaluating …
Endometriosis study begins recruitment in UK hospitals
May 28, 2026Clinical Research, Recruitment Cyclana Bio, endometriosis
Cyclana Bio has recruited the first patients into a 500-participant observational study investigating the biological mechanisms behind endometriosis, following approval …
Gesynta Pharma doses first patient in endometriosis phase 2 trial
April 14, 2026Research and Development Gesynta Pharma, endometriosis
Gesynta Pharma has dosed the first patient in its phase 2 clinical proof-of-concept trial of vipoglanstat. The trial, NOVA, is …
EndoCyclic New Drug application approved by US FDA for endometriosis treatment
March 24, 2026Research and Development EndoCyclic Therapeutics, FDA, endometriosis
EndoCyclic Therapeutics’ Investigational New Drug (IND) application for its lead programme, ENDO-205, has been approved by the US FDA. With …
Universal Quantum partners with Open Quantum Institute to tackle endometriosis with new technology
July 29, 2025Medical Communications, Research and Development Open Quantum Institute, Pain, Reproductive health, UN Sustainable Development Goals, United Nations, Universal Quantum, endometriosis, women's health
Based in Brighton, UK, Universal Quantum has joined the Open Quantum Institute (OQI) to explore how quantum computing could revolutionise …
The Problem of Endometriosis in the UK
July 7, 2025Research and Development NHS, Obstetrics & Gynaecology, Pain, Reproductive health, Theramex, endometriosis, gynaecology
When did we decide it was an acceptable condition of womanhood in the UK to live with chronic pain?
FDA approves first endometriosis pain management drug in a decade
July 25, 2018Research and Development, Sales and Marketing AbbVie, FDA, Neurocrine Biosciences, endometriosis, pharma
The FDA has confirmed its approval of AbbVie and Neurocrine Biosciences’ Orilissa (elagolix), a nonpeptide small molecule gonadotropin-releasing hormone (GnRH) …
Bayer in Oxford tie-up
July 11, 2014Research and Development, Sales and Marketing Bayer, Oxford, endometriosis, university
Bayer HealthCare and the UK’s University of Oxford have signed an agreement to look for new treatments for two common …
Bayer signs endometriosis pact
October 3, 2012Research and Development, Sales and Marketing Bayer, Evotec, endometriosis
Bayer HealthCare and Evotec have signed a five-year deal to look for three novel drugs to treat women with endometriosis. …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
